IP Library Assignment 063624/0547
Patent Assignment
Reel/Frame 063624/0547

Release of Security Interest

Recorded: 2023-05-11 Pages: 41
Assignor
ZOOLANDER SA LLC
Executed: 2023-05-09
Assignee
ZEALAND PHARMA A/S
SYDMARKEN 11, SØBORG, 2860, DENMARK
Covered Properties (70)
Method of Treating Anorexia Using Glucagon-Like-Peptide-2 (Glp-2) Analogues
Application: 17/154,620 →
Publication: US US20210309708A1
Acylated Glucagon Analogues
Application: 17/369,061 →
Publication: US US20220073583A1
Glucagon-Glp-1-Gip Triple Agonist Compounds
Application: 17/388,328 →
Publication: US US20210363213A1
Apparatus and Methods for Administering a Pharmaceutical Agent
Application: 16/935,506 →
Publication: US US20210068748A1
Gip Agonist Compounds and Methods
Application: 17/221,287 →
Publication: US US20220041676A1
Amylin Analogues
Application: 16/986,790 →
Publication: US US20210115104A1
Amylin Analogues
Application: 17/381,373 →
Publication: US US20210346468A1
Acylated Glp-1/Glp-2 Dual Agonists
Application: 17/834,062 →
Publication: US US20230405087A9
KV1.3 Blockers
Application: 17/679,925 →
Publication: US US20220251151A1
Gap Junction Intercellular Communication Modulators and Their Use for the Treatment of Diabetic Eye Disease
Application: 16/609,963 →
Publication: US US20200054602A1
Methods and Medical Uses Relating to the Treatment of Hypoglycaemia
Application: 16/630,034 →
Publication: US US20200176101A1
Dosage Regimes for the Administration of Glucagon-Like-Peptide-2 (Glp-2) Analogues
Application: 16/511,766 →
Publication: US US20200000883A1
Formulations of Glucagon-Like-Peptide-2 (Glp-2) Analogues
Application: 17/276,252 →
Publication: US US20220265551A1
Compstatin Analogues and Their Medical Uses
Application: 16/976,439 →
Publication: US US20230192770A1
Formulations of Glucagon-Like-Peptide-2 (Glp-2) Analogues
Application: 17/279,691 →
Publication: US US20220031810A1
Pharmaceutical Parenteral Composition of Dual GLP1/2 Agonist
Application: 17/617,670 →
Publication: US US20230212227A1
Pharmaceutical Parenteral Composition of Dual GLP1/2 Agonist
Application: 17/617,675 →
Publication: US US20220202704A1
Compstatin Analogues and Their Medical Uses
Application: 17/637,392 →
Publication: US US20220306695A1
Cyclic Peptides Multimers Targeting Alpha-4-Beta-7 Integrin
Application: 17/234,488 →
Publication: US US20210324007A1
Methods of Treating Chemotherapy-Induced Diarrhea/Mucositis Using Glucagon-Like-Peptide-2(Glp-2)Analogues
Patent: 7,745,403 →
Application: 11/595,496 →
Publication: US US20070117752A1
Glucagon-Like-Peptide-2 (Glp-2) Analogues
Patent: 8,263,552 →
Application: 12/643,233 →
Publication: US US20110098222A1
Treatment of Inflammatory Bowel Disease Using Glucagon-Like-Peptide-2 (Glp-2) Analogues
Patent: 8,163,696 →
Application: 12/643,261 →
Publication: US US20110152186A1
Glucagon-Like-Peptide-2 (Glp-2) Analogues
Patent: 9,125,882 →
Application: 13/536,377 →
Publication: US US20120289466A1
Method of Treating Stomach or Bowel-Related Disorders by Administering Glucagon-Like-Peptide-2 (Glp-2) Analogues
Patent: 9,580,487 →
Application: 14/847,938 →
Publication: US US20150368314A1
Glucagon-Like-Peptide-2 (Glp-2) Analogues
Patent: 7,563,770 →
Application: 11/429,168 →
Publication: US US20070231308A1
Modified Lysine-Mimetic Compounds
Patent: 8,431,540 →
Application: 13/234,956 →
Publication: US US20120245106A1
Modified Lysine-Mimetic Compounds
Patent: 8,026,272 →
Application: 12/610,172 →
Publication: US US20100249206A1
Modified Lysine-Mimetic Compounds
Patent: 7,622,496 →
Application: 11/643,192 →
Publication: US US20070149460A1
Peptide Conjugates of Glp-1 Receptor Agonists and Gastrin and Their Use
Patent: 9,649,362 →
Application: 14/735,738 →
Publication: US US20160184400A1
Peptide Conjugates of Glp-1 Receptor Agonists and Gastrin and Their Use
Application: 15/381,993 →
Publication: US US20170281709A1
Peptide Conjugates of Glp-1 Receptor Agonists and Gastrin and Their Use
Patent: 9,089,538 →
Application: 13/642,349 →
Publication: US US20130143793A1
Synthesis of Pyrrolidine Compounds
Patent: 8,927,590 →
Application: 13/593,110 →
Publication: US US20130053344A1
Synthesis of Pyrrolidine Compounds
Patent: 9,469,609 →
Application: 14/572,262 →
Publication: US US20150322007A1
Glp-1 Receptor Agonist Peptide Gastrin Conjugates
Patent: 9,861,706 →
Application: 14/864,540 →
Publication: US US20160082118A1
Glp-1 Receptor Agonist Peptide Gastrin Conjugates
Patent: 9,259,477 →
Application: 14/355,906 →
Publication: US US20140336107A1
Glucagon-Like-Peptide-2 (Glp-2) Analogues
Patent: 9,453,064 →
Application: 14/398,297 →
Publication: US US20150125431A1
Gip-Glp-1 Dual Agonist Compounds and Methods
Application: 14/398,260 →
Publication: US US20150299281A1
Glucagon Analogues
Patent: 9,975,939 →
Application: 14/864,256 →
Publication: US US20160009777A1
Glucagon Analogues
Application: 15/983,822 →
Publication: US US20190055296A1
Glucagon Analogues
Patent: 9,180,169 →
Application: 14/029,529 →
Publication: US US20140080757A1
Glucagon Analogues and Methods of Use
Application: 15/971,645 →
Publication: US US20180355010A1
Glucagon Analogues
Patent: 9,988,429 →
Application: 14/516,216 →
Publication: US US20150111817A1
Acylated Glucagon Analogues
Application: 15/852,458 →
Publication: US US20180141990A1
Acylated Glucagon Analogues
Application: 16/569,381 →
Publication: US US20200157168A1
Acylated Glucagon Analogues
Patent: 9,896,495 →
Application: 14/517,497 →
Publication: US US20150111826A1
Gip-Glp-1 Dual Agonist Compounds and Methods
Application: 16/112,926 →
Publication: US US20190218270A1
Gip-Glp-1 Dual Agonist Compounds and Methods
Application: 15/034,778 →
Publication: US US20160280754A1
Glucagon-Glp-1-Gip Triple Agonist Compounds
Application: 16/151,603 →
Publication: US US20190270789A1
Glucagon-Glp-1-Gip Triple Agonist Compounds
Application: 15/034,784 →
Publication: US US20160257729A1
Gip Agonist Compounds and Methods
Application: 16/281,347 →
Publication: US US20190256569A1
Gip Agonist Compounds and Methods
Application: 15/521,631 →
Publication: US US20170240609A1
Amylin Analogues
Application: 15/074,526 →
Publication: US US20160272693A1
Acylated Glucagon Analogue
Application: 16/410,736 →
Publication: US US20200087372A1
Acylated Glucagon Analogue
Application: 15/566,338 →
Publication: US US20180094038A1
Amylin Analogues
Application: 16/664,168 →
Publication: US US20200188485A1
Amylin Analogues
Application: 15/698,743 →
Publication: US US20180071366A1
Glp-1/Glp-2 Dual Agonists
Application: 16/466,930 →
Publication: US US20190338009A1
Acylated Glp-1/Glp-2 Dual Agonists
Application: 16/544,535 →
Publication: US US20190365865A1
Acylated Glp-1/Glp-2 Dual Agonists
Application: 16/841,104 →
Publication: US US20210244798A9
KV1.3 Blockers
Application: 17/356,354 →
Publication: US US20210380646A1
Fragment Synthesis of Substituted Cyclic Peptides
Application: 16/985,096 →
Publication: US US20200361944A1
Fragment Synthesis of Substituted Cyclic Peptides
Application: 15/775,319 →
Publication: US US20190077805A1
Cyclic Peptides Multimers Targeting Alpha-4-Beta-7 Integrin
Application: 16/348,103 →
Publication: US US20200216501A1
Homodetic Cyclic Peptides Targeting Alpha-4-Beta-7 Integrin
Application: 16/611,518 →
Publication: US US20200095285A1
Cyclic Amino Acid Molecules and Methods of Preparing the Same
Application: 14/962,952 →
Publication: US US20160222062A1
Cyclic Amino Acid Molecules and Methods of Preparing the Same
Patent: 9,260,479 →
Application: 13/257,159 →
Publication: US US20120065366A1
Aziridine Aldehydes, Aziridine-Conjugated Amino Derivatives, Aziridine-Conjugated Biomolecules and Processes for Their Preparation
Patent: 8,143,375 →
Application: 12/446,343 →
Publication: US US20100317832A1
Cyclic Peptides Targeting Alpha-4-Beta-7 Integrin
Application: 15/775,309 →
Publication: US US20200165300A1
Modified Lysine-Mimetic Compounds
Synthesis of Pyrrolidine Compounds
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Dec 13, 2017
From: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
To: ZEALAND PHARMA A/S
Reel/Frame 044378/0376 →
Assignment of Assignor's Interest Dec 13, 2017
From: MATHIESEN, JESPER MOSOLFF; VILLADSEN, JESPER SKODBORG; GIEHM, LISE; MUNCH, HENRIK KOFOED
To: ZEALAND PHARMA A/S
Reel/Frame 044378/0065 →
Assignment of Assignor's Interest Dec 13, 2017
From: HAMPRECHT, DIETER WOLFGANG; FOSSATI, GIACOMO
To: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Reel/Frame 044378/0207 →
Assignment of Assignor's Interest Dec 13, 2017
From: HEIM-RIETHER, ALEXANDER
To: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Reel/Frame 044378/0299 →
Assignment of Assignor's Interest Aug 29, 2019
From: SONNE, KIM; MOURITZEN, ULRIK; GLERUP, PETER; JEPPESEN, PALLE BEKKER
To: ZEALAND PHARMA A/S
Reel/Frame 050229/0478 →
Assignment of Assignor's Interest Dec 16, 2019
From: KIM, DONGJOON; ROY, SAYON
To: BOSTON MEDICAL CENTER CORPORATION
Reel/Frame 051297/0400 →
Assignment of Assignor's Interest Dec 16, 2019
From: LARSEN, BJARNE DUE; MOURITZEN, ULRIK
To: ZEALAND PHARMA A/S
Reel/Frame 051297/0392 →
Assignment of Assignor's Interest Feb 11, 2020
From: AANÆS WENDT, SABRINA
To: ZEALAND PHARMA A/S
Reel/Frame 051784/0878 →
Assignment of Assignor's Interest Feb 11, 2020
From: MADSEN, HENRIK; BAGTERP JØRGENSEN, JOHN
To: TECHNICAL UNIVERSITY OF DENMARK
Reel/Frame 051784/0928 →
Assignment of Assignor's Interest Feb 11, 2020
From: RANJAN, AJENTHEN; NØRGAARD, KIRSTEN; SCHMIDT, SIGNE
To: HVIDOVRE HOSPITAL
Reel/Frame 051784/0978 →
Assignment of Assignor's Interest Sep 15, 2020
From: DUE LARSEN, BJARNE; GIEHM, LISE; EDWARDS, ALISTAIR VINCENT GORDON
To: ZEALAND PHARMA A/S
Reel/Frame 053775/0761 →
Assignment of Assignor's Interest Nov 30, 2020
From: STEENSBERG, ADAM
To: ZEALAND PHARMA A/S
Reel/Frame 054492/0572 →
Assignment of Assignor's Interest Jan 12, 2021
From: DEMMER, OLIVER
To: ZEALAND PHARMA A/S
Reel/Frame 054966/0108 →
Assignment of Assignor's Interest Jan 12, 2021
From: JUST, RASMUS; GIEHM, LISE; VILLADSEN, JESPER SKODBORG; MUNCH, HENRIK KOFOED
To: ZEALAND PHARMA A/S
Reel/Frame 054892/0357 →
Assignment of Assignor's Interest Jan 12, 2021
From: HAMPRECHT, DIETER WOLFGANG
To: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Reel/Frame 054892/0522 →
Assignment of Assignor's Interest Jan 12, 2021
From: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
To: ZEALAND PHARMA A/S
Reel/Frame 054892/0560 →
Assignment of Assignor's Interest Jun 17, 2021
From: LARSEN, BJARNE DUE; PETERSEN, YVETTE MIATA
To: ZEALAND PHARMA A/S
Reel/Frame 056577/0718 →
Assignment of Assignor's Interest Jul 2, 2021
From: ENCYCLE THERAPEUTICS INC.
To: ZEALAND PHARMA A/S
Reel/Frame 056748/0073 →
Assignment of Assignor's Interest Jul 2, 2021
From: VÁZQUEZ, MANUEL PÉREZ; MORSHED, M. MONZUR; KAFAL, ADAM PAUL; HICKEY, JENNIFER L.
To: ENCYCLE THERAPEUTICS INC.
Reel/Frame 056748/0014 →
Assignment of Assignor's Interest Nov 24, 2021
From: HAMPRECHT, DIETER WOLFGANG
To: BI RESEARCH ITALIA S.A.S. DI BI IT S.R.L.
Reel/Frame 058206/0370 →
Assignment of Assignor's Interest Nov 24, 2021
From: BI RESEARCH ITALIA S.A.S. DI BI IT S.R.L.
To: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Reel/Frame 058206/0244 →
Assignment of Assignor's Interest Nov 24, 2021
From: BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG.
To: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Reel/Frame 058206/0262 →
Assignment of Assignor's Interest Nov 24, 2021
From: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
To: ZEALAND PHARMA A/S
Reel/Frame 058206/0452 →
Assignment of Assignor's Interest Nov 24, 2021
From: RIST, WOLFGANG
To: BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG.
Reel/Frame 058206/0476 →
Assignment of Assignor's Interest Nov 24, 2021
From: RIBER, DITTE; TOLBORG, JAKOB LIND
To: ZEALAND PHARMA A/S
Reel/Frame 058206/0514 →